Skip to main content
Premium Trial:

Request an Annual Quote

NanoString Technologies Announces Common Stock Offering

NEW YORK (GenomeWeb) – NanoString Technologies said today that it has made an agreement to sell 3 million shares of its common stock at $16.75 per share with RW Baird as the sole underwriter in a public offering pursuant to NanoString's existing shelf registration statement filed in 2014.

The firm has also granted Baird a 30-day option to purchase up to an additional 450,000 shares of common stock.

NanoString said it plans to use the net proceeds to support its general corporate activities and for working capital.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.